Last reviewed · How we verify
Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus
Approved treatments
- Noroxin
- Floxin
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus patent landscape — cliff calendar, originator estates, attackable patents
- Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus treatment landscape brief
- Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus treatment updates RSS
Frequently asked questions about Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus
What drugs treat Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus?
Tracked treatments include Noroxin, Floxin, Levaquin, Ofloxacine.
What is the treatment for Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus?
Standard treatment for Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus includes Noroxin, Floxin, Levaquin, Ofloxacine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus patent cliff · Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus CI report
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- Treatment: Ofloxacine · Assistance Publique - Hôpitaux de Paris
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing